Investors
Information Disclosure
-
VOLUNTARY ANNOUNCEMENT - APPOINTMENT OF CHIEF MEDICAL OFFICER AND HEADS OF CLINICAL DEVELOPMENT2026.04.28
-
NEXT DAY DISCLOSURE RETURN2026.04.27
-
NEXT DAY DISCLOSURE RETURN2026.04.24
-
NEXT DAY DISCLOSURE RETURN2026.04.23
-
NEXT DAY DISCLOSURE RETURN2026.04.22
-
VOLUNTARY ANNOUNCEMENT - LANOVA MEDICINES PRESENTED LATEST RESEARCH DATA ON TWO ADC PROGRAMS AT AACR 20262026.04.22
-
NEXT DAY DISCLOSURE RETURN2026.04.21
-
VOLUNTARY ANNOUNCEMENT - NEW INDICATION FOR BENMELSTOBART IN COMBINATION WITH ANLOTINIB FOR THE TREATMENT OF ALVEOLAR SOFT PART SARCOMA APPROVED FOR MARKETING2026.04.20